img

Global Drug Reprofiling Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug Reprofiling Market Research Report 2024

According to MRAResearch’s new survey, global Drug Reprofiling market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drug Reprofiling market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Reprofiling market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis AG
Abbott Healthcare
Pfizer
Johnson & Johnson
Hoffmann-La Roche
Sandoz
Mylan Inc.
Teva Pharmaceuticals
Segment by Type
Orally
Intravenously

Segment by Application


Central Nervous Disorders
Cardiovascular Disorders
Oncology
others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Drug Reprofiling report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Reprofiling Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Orally
1.2.3 Intravenously
1.3 Market by Application
1.3.1 Global Drug Reprofiling Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Central Nervous Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Oncology
1.3.5 others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Reprofiling Market Perspective (2018-2033)
2.2 Drug Reprofiling Growth Trends by Region
2.2.1 Global Drug Reprofiling Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drug Reprofiling Historic Market Size by Region (2018-2023)
2.2.3 Drug Reprofiling Forecasted Market Size by Region (2024-2033)
2.3 Drug Reprofiling Market Dynamics
2.3.1 Drug Reprofiling Industry Trends
2.3.2 Drug Reprofiling Market Drivers
2.3.3 Drug Reprofiling Market Challenges
2.3.4 Drug Reprofiling Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Reprofiling Players by Revenue
3.1.1 Global Top Drug Reprofiling Players by Revenue (2018-2023)
3.1.2 Global Drug Reprofiling Revenue Market Share by Players (2018-2023)
3.2 Global Drug Reprofiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Reprofiling Revenue
3.4 Global Drug Reprofiling Market Concentration Ratio
3.4.1 Global Drug Reprofiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Reprofiling Revenue in 2022
3.5 Drug Reprofiling Key Players Head office and Area Served
3.6 Key Players Drug Reprofiling Product Solution and Service
3.7 Date of Enter into Drug Reprofiling Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Reprofiling Breakdown Data by Type
4.1 Global Drug Reprofiling Historic Market Size by Type (2018-2023)
4.2 Global Drug Reprofiling Forecasted Market Size by Type (2024-2033)
5 Drug Reprofiling Breakdown Data by Application
5.1 Global Drug Reprofiling Historic Market Size by Application (2018-2023)
5.2 Global Drug Reprofiling Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug Reprofiling Market Size (2018-2033)
6.2 North America Drug Reprofiling Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Drug Reprofiling Market Size by Country (2018-2023)
6.4 North America Drug Reprofiling Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Reprofiling Market Size (2018-2033)
7.2 Europe Drug Reprofiling Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Drug Reprofiling Market Size by Country (2018-2023)
7.4 Europe Drug Reprofiling Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Reprofiling Market Size (2018-2033)
8.2 Asia-Pacific Drug Reprofiling Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Drug Reprofiling Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Reprofiling Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Reprofiling Market Size (2018-2033)
9.2 Latin America Drug Reprofiling Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Drug Reprofiling Market Size by Country (2018-2023)
9.4 Latin America Drug Reprofiling Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Reprofiling Market Size (2018-2033)
10.2 Middle East & Africa Drug Reprofiling Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Drug Reprofiling Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Reprofiling Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Drug Reprofiling Introduction
11.1.4 Novartis AG Revenue in Drug Reprofiling Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Detail
11.2.2 Abbott Healthcare Business Overview
11.2.3 Abbott Healthcare Drug Reprofiling Introduction
11.2.4 Abbott Healthcare Revenue in Drug Reprofiling Business (2018-2023)
11.2.5 Abbott Healthcare Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Drug Reprofiling Introduction
11.3.4 Pfizer Revenue in Drug Reprofiling Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Drug Reprofiling Introduction
11.4.4 Johnson & Johnson Revenue in Drug Reprofiling Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Hoffmann-La Roche
11.5.1 Hoffmann-La Roche Company Detail
11.5.2 Hoffmann-La Roche Business Overview
11.5.3 Hoffmann-La Roche Drug Reprofiling Introduction
11.5.4 Hoffmann-La Roche Revenue in Drug Reprofiling Business (2018-2023)
11.5.5 Hoffmann-La Roche Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Detail
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Drug Reprofiling Introduction
11.6.4 Sandoz Revenue in Drug Reprofiling Business (2018-2023)
11.6.5 Sandoz Recent Development
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Detail
11.7.2 Mylan Inc. Business Overview
11.7.3 Mylan Inc. Drug Reprofiling Introduction
11.7.4 Mylan Inc. Revenue in Drug Reprofiling Business (2018-2023)
11.7.5 Mylan Inc. Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Reprofiling Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Reprofiling Business (2018-2023)
11.8.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug Reprofiling Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Orally
Table 3. Key Players of Intravenously
Table 4. Global Drug Reprofiling Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Drug Reprofiling Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Drug Reprofiling Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Reprofiling Market Share by Region (2018-2023)
Table 8. Global Drug Reprofiling Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Drug Reprofiling Market Share by Region (2024-2033)
Table 10. Drug Reprofiling Market Trends
Table 11. Drug Reprofiling Market Drivers
Table 12. Drug Reprofiling Market Challenges
Table 13. Drug Reprofiling Market Restraints
Table 14. Global Drug Reprofiling Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Reprofiling Market Share by Players (2018-2023)
Table 16. Global Top Drug Reprofiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Reprofiling as of 2022)
Table 17. Ranking of Global Top Drug Reprofiling Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug Reprofiling Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Reprofiling Product Solution and Service
Table 21. Date of Enter into Drug Reprofiling Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Reprofiling Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Reprofiling Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Reprofiling Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Drug Reprofiling Revenue Market Share by Type (2024-2033)
Table 27. Global Drug Reprofiling Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Reprofiling Revenue Market Share by Application (2018-2023)
Table 29. Global Drug Reprofiling Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Drug Reprofiling Revenue Market Share by Application (2024-2033)
Table 31. North America Drug Reprofiling Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Drug Reprofiling Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drug Reprofiling Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Drug Reprofiling Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Drug Reprofiling Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drug Reprofiling Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Drug Reprofiling Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Drug Reprofiling Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drug Reprofiling Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Drug Reprofiling Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Drug Reprofiling Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drug Reprofiling Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Drug Reprofiling Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Drug Reprofiling Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drug Reprofiling Market Size by Country (2024-2033) & (US$ Million)
Table 46. Novartis AG Company Detail
Table 47. Novartis AG Business Overview
Table 48. Novartis AG Drug Reprofiling Product
Table 49. Novartis AG Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 50. Novartis AG Recent Development
Table 51. Abbott Healthcare Company Detail
Table 52. Abbott Healthcare Business Overview
Table 53. Abbott Healthcare Drug Reprofiling Product
Table 54. Abbott Healthcare Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 55. Abbott Healthcare Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Drug Reprofiling Product
Table 59. Pfizer Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Drug Reprofiling Product
Table 64. Johnson & Johnson Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Hoffmann-La Roche Company Detail
Table 67. Hoffmann-La Roche Business Overview
Table 68. Hoffmann-La Roche Drug Reprofiling Product
Table 69. Hoffmann-La Roche Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 70. Hoffmann-La Roche Recent Development
Table 71. Sandoz Company Detail
Table 72. Sandoz Business Overview
Table 73. Sandoz Drug Reprofiling Product
Table 74. Sandoz Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 75. Sandoz Recent Development
Table 76. Mylan Inc. Company Detail
Table 77. Mylan Inc. Business Overview
Table 78. Mylan Inc. Drug Reprofiling Product
Table 79. Mylan Inc. Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 80. Mylan Inc. Recent Development
Table 81. Teva Pharmaceuticals Company Detail
Table 82. Teva Pharmaceuticals Business Overview
Table 83. Teva Pharmaceuticals Drug Reprofiling Product
Table 84. Teva Pharmaceuticals Revenue in Drug Reprofiling Business (2018-2023) & (US$ Million)
Table 85. Teva Pharmaceuticals Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Reprofiling Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Drug Reprofiling Market Share by Type: 2022 VS 2033
Figure 3. Orally Features
Figure 4. Intravenously Features
Figure 5. Global Drug Reprofiling Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Drug Reprofiling Market Share by Application: 2022 VS 2033
Figure 7. Central Nervous Disorders Case Studies
Figure 8. Cardiovascular Disorders Case Studies
Figure 9. Oncology Case Studies
Figure 10. others Case Studies
Figure 11. Drug Reprofiling Report Years Considered
Figure 12. Global Drug Reprofiling Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Drug Reprofiling Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Drug Reprofiling Market Share by Region: 2022 VS 2033
Figure 15. Global Drug Reprofiling Market Share by Players in 2022
Figure 16. Global Top Drug Reprofiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Reprofiling as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Drug Reprofiling Revenue in 2022
Figure 18. North America Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Drug Reprofiling Market Share by Country (2018-2033)
Figure 20. United States Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Drug Reprofiling Market Share by Country (2018-2033)
Figure 24. Germany Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Drug Reprofiling Market Share by Region (2018-2033)
Figure 32. China Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Drug Reprofiling Market Share by Country (2018-2033)
Figure 40. Mexico Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Drug Reprofiling Market Share by Country (2018-2033)
Figure 44. Turkey Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Drug Reprofiling Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Novartis AG Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 47. Abbott Healthcare Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 50. Hoffmann-La Roche Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 51. Sandoz Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 52. Mylan Inc. Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Drug Reprofiling Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries